Clinical Trial Update: Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit [NA]

View source ↗

Summary

A completed clinical study evaluating DNA extracted from tumor tissue biopsies using the Therascreen KRAS RGQ PCR Kit in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Therascreen KRAS RGQ PCR Kit (KRAS RGQ PCR Kit)

Snippet

Sponsor: QIAGEN Gaithersburg, Inc | Conditions: Non-small Cell Lung Cancer | NA | Status: COMPLETED